Dk. Obatomi et al., CHANGES IN URINARY ENZYME LEVELS FOLLOWING THE USE OF ANTIHYPERTENSIVE AGENTS IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Cardiovascular drugs and therapy, 9(3), 1995, pp. 407-412
Citations number
18
Categorie Soggetti
Pharmacology & Pharmacy","Cardiac & Cardiovascular System
When choosing antihypertensive agents for the treatment of hypertensio
n, it is necessary to consider the predisposition of individuals to re
nal damage, which may be associated with the long-term effect of such
agents. In this respect, this study examined the effect of two commonl
y used antihypertensive drugs (Brinerdin and Minizide) on renal functi
on over 24 months in patients diagnosed as having essential hypertensi
on. We utilized urinary enzyme studies, which are indicators of subtle
renal dysfunction. Other parameters of glomerular and tubular functio
n were also determined in the pretreatment period, as well as during a
nd at the end of treatment of 28 patients (16 males and 12 females) wi
th therapeutic doses of Brinerdin and 22 patients (12 males and 10 fem
ales) with conventional doses of Minizide. During the follow-up period
, blood pressure (BP) fell from a mean of 160/108 +/- 9/4 (SD) mmHg to
130/90 +/- 7/4 on Brinerdin and from a mean of 160/106 +/- 5/2 (SD) m
mHg to 130/90 +/- 8/5 on Minizide. There was no significant difference
in the levels of BP between the patients taking Minizide and those ta
king Brinerdin before, during, and at the end of treatment. Significan
t elevation (p < 0.05) of the levels of urinary protein, lactate dehyd
rogenase (LDH), and N-acetyl-B-D-glycosaminidase (NAG) was observed in
patients on Minizide during treatment, and these levels remained elev
ated during the latter part of the study. Normotensive, untreated, age
- and sex-matched control subjects showed no such urinary parameter ch
anges. While NAG activity was significantly elevated in the Brinerdin-
treated patients, other parameters remained within comparable levels t
o those of normotensive, untreated control subjects throughout the per
iod of study. However, a significant reduction in the serum potassium
level (-0.58 +/- 0.06 mmol/l) was observed following Minizide therapy
compared with a mild reduction (-0.25 +/- 0.05 mmol/1) following Brine
rdin treatment. Female and male patients exhibited similar patterns of
response to the two drugs. The results of the present study suggest t
hat transient but subtle tubular injury has been induced by the use of
the two drugs with a more profound effect from the use of Minizide.